SEC Form 4 · accession 0001645470-19-000010
ENDONOVO THERAPEUTICS, INC. · ENDV
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Alan Brian Collier
Officer — CEO
Period of report
Feb 12, 2019
Accepted (ET)
Feb 15, 2019 · 9:36 am EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001528172
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | Feb 12, 2019 | P | 1,000 | $0.0223 | A | 21,132,623 | D | |
| Common Stock | Feb 12, 2019 | P | 5,000 | $0.0222 | A | 21,137,623 | D | |
| Common Stock | Feb 12, 2019 | P | 2,500 | $0.023 | A | 21,140,123 | D | |
| Common Stock | Feb 12, 2019 | P | 2,500 | $0.023 | A | 21,142,623 | D | |
| Common Stock | Feb 12, 2019 | P | 5,000 | $0.023 | A | 21,147,623 | D | |
| Common Stock | Feb 12, 2019 | P | 10,000 | $0.0229 | A | 21,157,623 | D | |
| Common Stock | Feb 12, 2019 | P | 5,000 | $0.0226 | A | 21,162,623 | D | |
| Common Stock | Feb 12, 2019 | P | 5,000 | $0.0228 | A | 21,167,623 | D | |
| Common Stock | Feb 12, 2019 | P | 5,000 | $0.0229 | A | 21,172,623 | D | |
| Common Stock | Feb 12, 2019 | P | 5,000 | $0.0228 | A | 21,177,623 | D | |
| Common Stock | Feb 12, 2019 | P | 5,000 | $0.0229 | A | 21,182,623 | D | |
| Common Stock | Feb 12, 2019 | P | 1,000 | $0.0228 | A | 21,183,623 | D | |
| Common Stock | Feb 12, 2019 | P | 10,000 | $0.0222 | A | 21,193,623 | D | |
| Common Stock | Feb 12, 2019 | P | 1,000 | $0.0229 | A | 21,194,193 | D | |
| Common Stock | Feb 12, 2019 | P | 10,000 | $0.0226 | A | 21,204,623 | D | |
| Common Stock | Feb 12, 2019 | P | 5,000 | $0.0228 | A | 21,209,623 | D | |
| Common Stock | Feb 12, 2019 | P | 10,000 | $0.0229 | A | 21,219,623 | D | |
| Common Stock | Feb 12, 2019 | P | 10,000 | $0.0229 | A | 21,229,623 | D | |
| Common Stock | Feb 12, 2019 | P | 5,000 | $0.0229 | A | 21,234,623 | D | |
| Common Stock | Feb 12, 2019 | P | 10,000 | $0.0229 | A | 21,244,623 | D | |
| Common Stock | Feb 12, 2019 | P | 10,000 | $0.0229 | A | 21,254,623 | D | |
| Common Stock | Feb 12, 2019 | P | 5,000 | $0.0228 | A | 21,259,623 | D | |
| Common Stock | Feb 12, 2019 | P | 5,000 | $0.0229 | A | 21,264,623 | D | |
| Common Stock | Feb 12, 2019 | P | 10,000 | $0.0221 | A | 21,274,623 | D | |
| Common Stock | Feb 12, 2019 | P | 10,000 | $0.0221 | A | 21,284,623 | D | |
| Common Stock | Feb 12, 2019 | P | 10,000 | $0.0222 | A | 21,294,623 | D | |
| Common Stock | Feb 12, 2019 | P | 15,000 | $0.0222 | A | 21,309,623 | D | |
| Common Stock | Feb 12, 2019 | P | 10,000 | $0.0223 | A | 21,319,623 | D | |
| Common Stock | Feb 12, 2019 | P | 10,000 | $0.0223 | A | 21,329,623 | D | |
| Common Stock | Feb 12, 2019 | P | 15,000 | $0.0223 | A | 21,344,623 | D |
Table II — derivative securities
No Table II lines on this filing.